🇺🇸 FDA
Pipeline program

CNSA-001

GAS-001

Phase 2 small_molecule completed

Quick answer

CNSA-001 for Gastroparesis is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PTC THERAPEUTICS, INC.
Indication
Gastroparesis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials